is being presented by Vladimir Shnaydman, President, of ORBee Consulting and airs on Wednesday, September 15th, 2010. For more details or to register, please visit our site at www.fxconferences.com
Under constant pressure to reduce the cost of drug development, many biopharmaceutical companies and CROs are looking for ways to improve their capacity planning and resource allocation. It is critical for clinical organizations to find a better approach to increase effectiveness in resource capacity planning, especially for a portfolio of clinical trials. An optimal capacity planning solution includes proper resource utilization, allocation between ongoing and new trials, outsourcing strategy, hiring trend and budget allocation strategy for a variety of employee roles, and resource reallocation due to new or cancelled trials. It means identifying resource bottlenecks and optimal scheduling of new trials.
In this presentation, the speaker discusses a powerful decision-making methodology based on rigorous mathematical models for optimal capacity planning and resource allocation in clinical research, a technique which has been shown to reduce costs by up to 30% in some cases by uncovering better resource allocation solutions.
